From the Departments of Biochemistry and § Veteran's Affairs Medical Center and of Medicine, Case Western Reserve University, Cleveland, Ohio 44106-4935
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
A new protein with translational activity has been identified on the basis of its ability to stimulate translation in an in vitro globin synthesis assay deficient in eukaryotic initiation factor (eIF) 4B and eIF4F. This protein has been purified to greater than 80% homogeneity from rabbit reticulocyte lysate and has been given the name eIF4H. eIF4H was shown to stimulate the in vitro activities of eIF4B and eIF4F in globin synthesis, as well as the in vitro RNA-dependent ATPase activities of eIF4A, eIF4B, and eIF4F. Three tryptic fragments of eIF4H yielded amino acid sequences that were 100% identical to a human sequence found in the GeneBankTM that codes for a previously uncharacterized protein (HUMORFU_1). The calculated molecular weight of the protein encoded by this sequence, its predicted cyanogen bromide fragmentation, and calculated isoelectric point are all consistent with those determined experimentally for eIF4H. Also, the presence of an RNA recognition motif within HUMORFU_1 suggests that eIF4H may interact with mRNA. We conclude that this newly characterized protein, eIF4H, functions to stimulate the initiation of protein synthesis at the level of mRNA utilization, and is encoded by the gene for HUMORFU_1.
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Protein synthesis is the process by which an mRNA sequence is translated into protein on ribosomes using aminoacyl-tRNAs as substrates. In eukaryotes, this process involves many accessory proteins, which are transiently associated with the ribosome and function either in the initiation, elongation, or termination of protein synthesis. The steps involving delivery of the mRNA to the ribosome and positioning of the first initiating methionyl-tRNA (Met-tRNAi)1 at the AUG start codon is termed initiation. This process involves at least 11 protein initiation factors (for a recent review on translation, see Merrick and Hershey (1)).
The first step in the initiation of the majority of mRNAs is the specific recognition of the 7-methylguanosine (m7G) cap of the mRNA by the multisubunit complex eukaryotic initiation factor (eIF) 4F. eIF4F is composed of three protein subunits, eIF4E (25 kDa), eIF4A (46 kDa), and eIF4G (150 kDa). The interaction of eIF4F with the m7G cap is facilitated specifically through the eIF4E subunit (2). Following binding of the eIF4F complex to the 5' end of mRNA, the initiation factors eIF4A (46 kDa) and the eIF4B dimer (160 kDa) interact with the mRNA and facilitate "melting" of mRNA secondary structure through the helicase activity of eIF4A (3). This mechanism facilitates binding of the 40 S ribosomal subunit to the 5' end of the mRNA and may also provide the motor for the ATP-dependent process of scanning.
The other major step in the initiation of protein synthesis involves binding of the first aminoacyl-tRNA, Met-tRNAi, to the 40 S ribosomal subunit. This is facilitated by the translation factors eIF1A,2 eIF2, and eIF3. The Met-tRNAi forms a ternary complex (3°) with eIF2 and GTP (3° = eIF2·GTP·Met-tRNAi) that will then bind to the 40 S ribosomal subunit to form the 43 S preinitiation complex (40 S·eIF1A·eIF3·3°) (1). The 43 S complex binds to unfolded mRNA near the m7G cap, which may involve an interaction of the complexed eIF3 with the eIF4G subunit of eIF4F (4). The 43 S complex "scans" down the mRNA until the initiator AUG codon is recognized by the Met-tRNAi (1). Once the ribosome is in the correct position, eIF5 promotes the hydrolysis of the GTP in the 3° complex to GDP (1, 5, 6), causing the release of the 40 S-associated initiation factors and leaving a 40 S·Met-tRNAi·mRNA complex. Subsequently, the 60 S ribosomal subunit joins to form 80 S ribosomes on the mRNA with the Met-tRNAi positioned in the P site of the ribosome (1). In this state, the ribosome is ready to begin the elongation phase of protein synthesis.
Many of the factors involved in the initiation of eukaryotic protein synthesis as described above have been purified and characterized, although there is still an enormous amount of information not yet known about the details of initiation. The last eukaryotic initiation factor to be biochemically identified and characterized was eIF4F (7). Subsequently, several attempts have been made to identify novel initiation factors by genetic studies (8-10). These studies have yielded several proteins characterized as essential for protein synthesis of uniquely selected mRNA. Several of these were found to code for known translation factors (10), while some were found to also have additional primary functions (8). Here we report the biochemical purification and characterization of a new protein from rabbit reticulocyte lysate that stimulates translation. This protein's identity was determined by amino acid sequencing and it was defined as a unique translation factor with a sequence identical to a protein found in the data base of undescribed function. In the following article, the activities and characteristics of this protein, which has been named eIF4H, are described.
![]() |
EXPERIMENTAL PROCEDURES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Materials
Reagents were purchased from the following suppliers: rabbit
reticulocyte lysate from Green Hectares, Oregon, WI; Sephadex G-75,
Sephadex G-75 superfine, and Ultrogel AcA-34 chromatography resins from
Amersham Pharmacia Biotech; CM-cellulose (type 52), DEAE-cellulose
(type 52), and phosphocellulose (type P-11) from Whatman; SynChropak
RP-P-100 C-18 reverse phase HPLC column from SynChrom Incorporated;
isoelectric focusing (IEF) and high molecular weight SDS-polyacrylamide
gel electrophoresis (PAGE) standards from Bio-Rad; high and low
molecular weight rainbow-labeled SDS-PAGE protein standards from
Amersham Pharmacia Biotech; nonequilibrium pH gradient electrophoresis
(NEPHGE) protein standards from Life Technologies, Inc.; polyvinylidene
difluoride membrane (Immobilon-P) and nitrocellulose filters (type HA)
from Millipore Corporation; pH 3.5-10 ampholytes from Amersham
Pharmacia Biotech; pH 7-9 and pH 8-10 ampholytes from Bio-Rad;
[14C]leucine and [-32P]ATP from NEN Life
Science Products; and trypsin, phosphoenolpyruvate, and pyruvate kinase
from Sigma.
Methods
Purification of eIF4H from Rabbit Reticulocyte Lysate-- Purification of eIF4H follows the standard procedures used to purify protein translation initiation factors (7, 11) with some modifications and additions as outlined below. All steps in the purification of eIF4H were performed at 4 °C. Rabbit reticulocyte lysate was centrifuged at 100,000 × g for 3 h to pellet polysomes. Polysome pellets were then washed and resuspended in a 250 mM sucrose, 1 mM DTT, 0.1 mM EDTA buffer. Solid KCl was added to a 500 mM final concentration to dissociate ribosomes and mRNA from the translation initiation factors. Ribosomes were pelleted at 100,000 × g for 4 h, and the supernatant, containing initiation factors, was dialyzed against a 150 mM KCl standard buffer (SB) (20 mM Tris (pH 7.5), 1 mM DTT, 0.1 mM EDTA) with 10% glycerol, and applied to a phosphocellulose column equilibrated with this same buffer. Initiation factors eIF2A, eIF3, eIF4B, eIF4F, and eIF4H were eluted with SB + 450 mM KCl + 10% glycerol.
Initiation factors in the 450 mM KCl wash, including eIF4H, were further separated within a 5-15% (w/v) sucrose gradient containing 500 mM KCl at 26,000 rpm for 24 h in a Beckman SW28 rotor. In this step, the large eIF3 complex (16 S) could be purified away from the other initiation factors which sediment more slowly. The factors eIF4F, eIF4B, eIF2A, and eIF4H were then separated by size using an Ultrogel AcA-34 gel filtration column equilibrated with SB + 500 mM KCl + 25% glycerol at a flow rate of 0.5 ml/min. At this point, 25% glycerol was necessary to help stabilize eIF4H, which was found to lose activity rapidly over time in the standard 10% glycerol buffer used previously. Next, eIF4H was passed over DEAE- and CM-cellulose in SB + 50 mM KCl + 25% glycerol at a flow rate of 0.3 ml/min, both of which do not bind eIF4H, to remove the majority of the contaminants and eIF2A. Finally, eIF4H was purified from higher molecular weight contaminants using a Sephadex G-75 superfine column equilibrated with SB + 50 mM KCl + 25% glycerol at a flow rate of 4 ml/h resulting in a final product which was ~80% pure for eIF4H as determined by SDS-PAGE (12).SDS-PAGE-- SDS-PAGE was performed as described by Laemmli (12). Separating gels used were 12.5% acrylamide (unless otherwise noted) and 0.213% bisacrylamide (ratio acrylamide:bisacrylamide, 58.7:1).
Size Exclusion Chromatography-- The native molecular weight of eIF4H was determined by size exclusion chromatography using a Sephadex G-75 column and standards of known molecular weight. The column was equilibrated in HSB (20 mM HEPES (pH 7.5), 1 mM DTT, 0.1 mM EDTA) + 100 mM KCl + 25% glycerol and developed at a flow rate of 8 ml/h. The elution volume (Ve) for eIF4H was determined by assaying fractions in a globin synthesis assay deficient in eIF4B and eIF4F as well as by SDS-PAGE. The Ve for the standards was determined by SDS-PAGE and Kav was calculated as described previously (13). The native molecular weight of eIF4H was interpolated from a standard curve of the Kav versus the log of the molecular weight.
Globin Synthesis Assay-- Initiation factors were analyzed in a reconstituted rabbit reticulocyte lysate system lacking eIF4B, eIF4F, and eIF4H, by measuring the incorporation of [14C]leucine into newly synthesized globin as described previously (7, 14). Briefly, 50-µl reactions contained 20 mM HEPES (pH 7.5), 80 mM KCl, 1 mM DTT, 3 mM Mg(CH3CO2)2, purified elongation factors, aminoacyl-tRNA synthetases, ribosomes, globin mRNA, tRNA, 80 µM amino acids (minus leucine), 0.3 µCi of [14C]leucine (specific activity, 320 µCi/µmol), 1 mM ATP, 0.2 mM GTP, 0.34 unit of pyruvate kinase, and 3 mM phosphoenolpyruvate. The remaining initiation factors (eIF1A, eIF2, eIF4A, eIF5, and eIF5A) were added to the assay in partially purified form as fractions from phosphocellulose, except for eIF3, which was added in its purified form from sucrose gradients. The incorporation of [14C]leucine into hot trichloroacetic acid-precipitable protein was measured after a 20-min incubation at 37 °C by scintillation spectrometry. The amounts of initiation factors eIF4B, eIF4F, and eIF4H added are given in the legend of Table I.
RNA-dependent ATP Hydrolysis Assay--
Combinations
of the initiation factors eIF4A, eIF4F, eIF4B, and eIF4H were used to
investigate RNA-dependent ATP hydrolysis by measuring the
release of 32Pi from [-32P]ATP
as described previously (15). Briefly, 20-µl reactions contained 15 mM HEPES (pH 7.5), 80 mM KCl, 2.5 mM Mg(CH3CO2)2, 1 mM DTT, 100 µM [
-32P]ATP
(specific activity, 2000-4000 cpm/pmol), and various concentrations and combinations of initiation factors. Reactions were incubated at
37 °C for 15 min, and 32Pi release was
quantitated by organic extraction. The amounts of initiation factors
eIF4B, eIF4F, and eIF4H added are shown in the legend of Table II.
Amino Acid Analysis and Protein Sequencing of eIF4H-- Approximately 2 µg of eIF4H was subjected to electrophoresis in an 18% polyacrylamide SDS-gel and transferred to a polyvinylidene difluoride membrane in 20% methanol, 10 mM Na3PO4 (pH 12) for 1 h at 12 V. The membrane was stained for 5 min in 50% methanol, 10% acetic acid, 0.5 mM Coomassie Brilliant Blue and then destained in 50% methanol, 10% acetic acid. Finally, the membrane was washed several times in double distilled H2O to remove any remaining glycine, and the 25-kDa band (eIF4H) was cut out and subjected to analysis using an Applied Biosystems amino acid analyzer, or amino acid sequencing by Edman degradation using an Applied Biosystems Procise protein sequencer (Molecular Biology Core Laboratory, Case Western Reserve University).
Cyanogen bromide digestion was performed as follows. Approximately 18 µg (~500 pmol) of eIF4H were precipitated in 10% ice-cold trichloroacetic acid on ice for 45 min, and then pelleted in a microcentrifuge at full speed (14,000 rpm) for 15 min at 4 °C. The protein pellet was allowed to air-dry and then washed twice with ice-cold acetone and air-dried again. Afterward, the protein was resuspended in 70% formic acid containing 500 µg of CNBr and allowed to digest for 16 h at room temperature in the dark. Ten volumes of double distilled H2O were added, and the sample was lyophilized to remove formic acid. This was repeated two more times to remove as much formic acid as possible. The peptides were dissolved in SDS-gel sample buffer, neutralized with Tris (pH 9), then loaded onto an 18% polyacrylamide SDS-gel and subsequently transferred to polyvinylidene difluoride as described above. For tryptic digestion, approximately 50 µg (~1400 pmol) of eIF4H was digested with 0.5 µg of trypsin in 50 mM Tris (pH 7.5), 10 mM CaCl for 2-3 h at 37 °C in a 40 µl reaction. Then an additional 0.5 µg of trypsin was added, and incubation was continued for 16 h at 37 °C. The sample was diluted with 300 µl of 0.05% trifluoroacetic acid, applied to a C-18 reverse phase HPLC column, and peptides were eluted with a 4.5-h 0-50% acetonitrile, 0.05% trifluoroacetic acid gradient. Peaks were detected at both 220 and 280 nm, and 1-ml fractions were collected. Major UV-absorbing peaks were chosen and concentrated under vacuum prior to amino acid sequencing.Two-dimensional Gel Electrophoresis-- Purified eIF4H was prepared for two-dimensional electrophoresis by lyophilization and resuspension in sample buffer containing 2% CHAPS, 9.8 M urea, 100 mM DTT, and 2% ampholytes (pH 3.5-10). Approximately 0.5 µg of eIF4H was analyzed in the first dimension on a 7.5-cm tube gel using a Hoefer SE 220 minigel tube gel adapter. Tube gels for IEF contained 3% polyacrylamide (acrylamide:bisacrylamide, 20:1), 2% Nonidet P-40, 2.2% ampholytes (an equal mixture of pH 3.5-10, 7-9, and 8-10 ampholytes), and 9.8 M urea. The gel was preelectrophoresed for 30 min at 500 V, and then the sample was loaded and electrophoresed toward the anode for 195 min at 500 V. The upper reservoir (cathode) buffer was 40 mM NaOH and the lower reservoir (anode) buffer was 40 mM o-phosphoric acid. For NEPHGE, the tube gels were similar to those used for IEF, except that the ampholyte concentration was reduced to 1.66% and was an equal mixture of pH 3.5-10 and 8-10 ampholytes. The upper reservoir (anode) buffer used was 40 mM o-phosphoric acid and the lower reservoir (cathode) buffer was 40 mM NaOH. The gels were not preelectrophoresed and electrophoresis was toward the cathode for 70 min at 500 V.
Prior to electrophoresis in the second dimension, the tube gels were equilibrated for 15 min in 60 mM Tris (pH 6.8), 2% SDS, 100 mM DTT, 10% glycerol. The gels were fixed to the top of 8 × 10 × 1.5-cm polyacrylamide slab gels with 1% agarose containing 24 mM Tris (pH 8.3), 200 mM glycine, 0.1% SDS. The second dimension gels were poured without a stacking gel and were 15% polyacrylamide (acrylamide:bisacrylamide, 37.5:1), 375 mM Tris (pH 8.8), 0.1% SDS. Electrophoresis was in buffer as described by Laemmli (12) at 35 mA for 40 min. Following electrophoresis, proteins were visualized by silver staining, as described by Blum et al. (16). Ribosomal proteins were prepared as described previously (17) with a few modifications as described below. Two hundred A260 units of polysomes were pelleted through a 1.0 M sucrose cushion containing 20 mM Tris (pH 7.5), 80 mM KCl, 2 mM Mg(CH3CO2)2, and 1 mM EDTA for 5 h at 40,000 rpm in a Beckman type 75Ti rotor at 4 °C. The polysome pellet was resuspended in a 0.25 M sucrose solution containing 20 mM Tris (pH 7.5), 80 mM KCl, 2 mM Mg(CH3CO2)2, and 1 mM EDTA. Twenty A260 units of the sucrose-washed polysomes were treated with two volumes of glacial acetic acid and incubated for 30 min at 4 °C. RNA was pelleted by centrifugation in a Microfuge at 14,000 rpm for 30 min and the supernatant was treated with five volumes of acetone and incubated for 30 min at 4 °C. The ribosomal proteins were pelleted in a Microfuge at 14,000 rpm 30 min and resuspended in 100 µl of IEF buffer (2% CHAPS, 9.8 M urea, 100 mM DTT, 2% ampholytes (pH 3.5-10)), and 7.5 µl of polysomal proteins were loaded onto the gel. ![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Purification of a New Translation Factor, eIF4H-- During the purification of eIF4B and eIF4F from rabbit reticulocyte lysate, an additional protein possessing translational activity was identified on the basis of its ability to stimulate protein translation in an in vitro globin synthesis assay deficient in eIF4B and eIF4F (Fig. 1). This new activity was found to elute from an Ultrogel AcA-34 gel filtration column later than eIF4F and eIF4B. This factor has been named eIF4H based on its various activities associated with mRNA utilization in protein translation, as will be described in this article. During further rounds of purification, eIF4H's stimulatory activity was found to be unstable in the standard buffers containing 10% glycerol, which may explain why the factor was not identified earlier. Subsequent steps employed buffers containing 25% glycerol, which have been used previously in the purification of eukaryotic elongation factor (eEF) 1A to maintain its stability and activity (18). Purification of eIF4H by its activity, as described under "Methods," resulted in a greater than 80% pure preparation containing a polypeptide band with an apparent molecular weight of 25 kDa by SDS-polyacrylamide gel electrophoresis (Fig. 2A), and a native molecular mass of 36.75 kDa as determined by gel filtration chromatography (Fig. 2B). This discrepancy in size may indicate that the native protein has a nonglobular, asymmetric conformation, therefore affecting its mobility on the column.
|
|
|
Translational Activities of eIF4H-- Purified eIF4H was found to barely stimulate protein synthesis (18% increase over background), if at all, in a globin synthesis assay deficient in eIF4B, eIF4F, and eIF4H (Table I). This low activity was different than that which had initially been seen during purification of eIF4H on the AcA-34 column (230% increase over background, Fig. 1). These fractions, though, may have been contaminated with small amounts of eIF4B, which then contributed to the higher levels of activity seen. When assayed at saturating levels, eIF4F by itself stimulated globin synthesis slightly better than eIF4H (Table I), while eIF4B stimulated synthesis by 3-fold over background. The combination of eIF4B + eIF4F increased activity by an additional 2-fold over that seen with eIF4B alone, and the combination of all three factors, eIF4B + eIF4F + eIF4H, led to an additional 30% increase in globin synthesis over that seen with eIF4B + eIF4F only.
|
|
|
Amino Acid Sequence of eIF4H-- To further characterize eIF4H, and to confirm that it is truly a unique translation factor, the protein was subjected to amino acid sequencing. Amino-terminal sequencing of eIF4H resulted in no detectable sequence, suggesting that the amino terminus is blocked. Therefore, eIF4H was digested with trypsin, fragments were separated by reverse phase HPLC, and peptides were subjected to sequencing by Edman degradation. Because eIF4H was the main component of this preparation (greater than 80%), major peaks seen by HPLC analysis represent eIF4H peptide fragments. Several peaks yielded amino acid sequences, and these are shown in Fig. 5A.
|
Predicted Physical Characteristics of HUMORFU_1-- The amino acid sequence of HUMORFU_1 was further analyzed using various sequence analysis programs. The calculated molecular mass of HUMORFU_1 was 25.2 kDa, which is similar to that seen for rabbit eIF4H, and its amino acid composition was found to be similar to that obtained for eIF4H by amino acid hydrolysis (data not shown). Cyanogen bromide digestion of HUMORFU_1 was predicted to result in three fragments, an amino-terminal fragment of 17.3 kDa, and two additional fragments equaling 1.6 and 6.1 kDa each. Cyanogen bromide digestion of rabbit eIF4H yielded bands with molecular masses of ~18 kDa and ~7 kDa (Fig. 6). The 17.3- and 6.1-kDa predicted fragments coincide with what was seen experimentally with eIF4H, while the 1.6-kDa predicted fragment was not visualized on the gel. This was most likely due to its small molecular weight causing it to migrate with the dye front. Attempts to sequence the 18-kDa peptide fragment were unsuccessful, suggesting that it is amino-terminally blocked. This coincides with the 17.3-kDa predicted fragment of HUMORFU_1 being the amino-terminal peptide fragment. The 7-kDa band from eIF4H cyanogen bromide digestion did not transfer well to a polyvinylidene difluoride membrane and therefore was not sequenced.
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In this report, we have described a novel translational activity that stimulates protein synthesis in a reconstituted reticulocyte lysate system. This activity has been purified to near homogeneity from rabbit reticulocyte lysate and was identified as a protein of 25-kDa molecular mass. This protein has been shown to stimulate the translational activities of eIF4B and eIF4F in an in vitro globin synthesis assay, as well as stimulate the RNA-dependent ATP hydrolysis activities of the initiation factors eIF4A, eIF4B, and eIF4F. Amino acid sequencing has identified this new protein as being coded by the gene KIAA0038 for the human open reading frame, HUMORFU_1, a previously uncharacterized protein whose predicted physical characteristics are identical to those seen experimentally for the purified rabbit protein.
Stimulation of globin synthesis by this newly purified protein may occur at any step during protein synthesis (initiation or elongation), but the stimulation of the ATPase activities of eIF4A, eIF4B and eIF4F strongly indicates that it functions during the same steps in initiation of protein synthesis involving mRNA utilization that these eIF4 factors do. Historically, the initiation factors that interact with mRNA and involve subsequent binding of the mRNA to the 43 S preinitiation complex are placed in the eIF4 group. Therefore, we have named this new translation factor eIF4H, and believe that it most likely interacts with one or more of the previously characterized eIF4 proteins to stimulate their activities.
When analyzed in in vitro translation assays, eIF4H stimulated the globin synthesis activities of eIF4B + eIF4F by 30% (Table I), while it stimulated the ATPase activities of eIF4A + eIF4B and eIF4A + eIF4B + eIF4F by 130% and 71%, respectively (Table II). The limited stimulation of eIF4B and eIF4F activities by eIF4H in the globin synthesis assay relative to the stimulation of eIF4A, eIF4B, and eIF4F activities in the ATPase assay is most likely due to the fact that subsaturating levels of proteins were used in the ATPase assay, while saturating levels of the initiation factors were used in the globin synthesis assay. Because eIF4H stimulated globin synthesis in the presence of saturating levels of both eIF4B and eIF4F (Table I), and eIF4H on its own had very little activity, it would appear that eIF4H's stimulatory activity is not due to contamination with either eIF4B or eIF4F and that eIF4H is a unique and real protein synthesis stimulatory factor.
eIF4H did show a higher level of stimulation in the globin synthesis assay (300-400% increase), as well as in the ATPase assay (200% increase), when it was measured using subsaturating levels of eIF4B (Figs. 3B and 4A, respectively). The dramatic stimulation seen at subsaturating levels of eIF4B in Fig. 3B show that the activities of eIF4H and eIF4B in the globin synthesis assay are not merely additive, and we can conclude that eIF4H does function as a stimulatory factor in protein synthesis. A similar increase in eIF4B's ATPase stimulatory activity was observed in Fig. 4A. What is striking is the similarity in the shape of the curves when comparing Fig. 3B and Fig. 4A, and suggests that eIF4H functions the same in the two different assays. Conversely, in Fig. 4B we see that eIF4H does not enhance eIF4F's activity at low concentrations, but that their RNA-dependent ATPase activities are additive. It is possible that eIF4H acts as a stimulatory protein which functions primarily to augment eIF4B's activities, or it may function when levels of eIF4B are limiting.
Initial mRNA-binding studies suggest that there is at least a weak association of eIF4H with mRNA. This is also substantiated by eIF4H's interaction with phosphocellulose requiring an ionic strength of approximately 225 mM for elution. Yet, eIF4H does not enhance the ATP-dependent RNA-binding of eIF4A, eIF4B, and eIF4F in preliminary assays (data not shown), but does stimulate the RNA-dependent ATP hydrolysis activity of these factors (Table II). This apparent discrepancy may be due to the differences in reaction conditions between the two assays, or that the eIF4H-mRNA complex is not stable enough to fully stimulate the mRNA-binding assay. Another possibility may be that eIF4H's stimulatory activity is exhibited not through an enhancement of binding affinities (Km) of the factors for mRNA, but through the enhancement of the factors' catalytic activities (Vmax) in ATP hydrolysis. In the case of eIF4B, it has been shown that the addition of this factor increases both the Vmax of ATP hydrolysis by eIF4A, as well as (and more dramatically) the Kact (similar to Km) of eIF4A for mRNA (23). When all three initiation factors (eIF4A + eIF4B + eIF4F) were present in ATPase reactions, an additional increase in the Vmax was also seen (23). The exact effect of eIF4B and eIF4F on eIF4A's ATPase activity when all factors are present in the assay is quite complicated, and suggests that the kinetics of this reaction are not simply defined. The addition of eIF4H may add yet another level of complexity to our understanding of this reaction. Furthermore, it is possible that eIF4H may react more strongly with the initiation factors than with mRNA, and therefore exhibit its stimulatory activity through these interactions and not necessarily through stimulation of RNA binding per se.
eIF4H has been shown to be separate from other initiation factors characterized so far by SDS-PAGE (Fig. 2A), as well as through differential interactions with various chromatographic resins during purification. To demonstrate that eIF4H is a nonribosomal protein, we utilized two-dimensional polyacrylamide electrophoresis to show that eIF4H has a differential mobility relative to other ribosomal proteins (Fig. 7, B and C). Also, if eIF4H were indeed a ribosomal protein, it should be present in levels equimolar to the other ribosomal proteins, yet eIF4H is not visible in a gel containing only polysomal proteins. These data prove that eIF4H is a nonribosomal protein, as well as support its identity as a distinct initiation factor.
eIF4H has also been identified as a unique translation factor by amino
acid sequencing and therefore does not represent a truncated form of
any other initiation factor or previously characterized ribosomal
protein. Several peptide sequences from eIF4H were found to match
identically to portions within the sequence encoded by the gene for the
human open reading frame, HUMORFU_1. We believe that the sequence for
HUMORFU_1 is identical to that for rabbit eIF4H due to the precedence
for mammalian translation factors to all be 93% identical to each
other (24).
The amino terminus of eIF4H was shown to be blocked due to the inability to sequence either the amino terminus of the intact protein or the 17-kDa band seen during cyanogen bromide digestion that represents the amino-terminal fragment by comparison to the predicted fragmentation of HUMORFU_1. Blockage of the amino terminus is a common feature seen for most of the eukaryotic protein translation factors sequenced so far (25). This process involves the cleavage of the amino-terminal methionine by aminopeptidase (26) and subsequent blockage of the new amino terminus by the addition of an acetyl group to this residue by amino-terminal acetylase (27, 28). The presence of either an alanine, glycine, serine, or threonine as the second amino acid in the protein promotes this process (26). The second amino acid in the sequence for HUMORFU_1 is an alanine, suggesting that this protein would be amino-terminally blocked in eukaryotes.
Other physical properties of eIF4H determined experimentally (molecular
weight, isoelectric point, and amino acid composition) are consistent
with those predicted for HUMORFU_1, supporting the identity of eIF4H as
the protein encoded by the gene for HUMORFU_1. An analysis of the amino
acid sequence of HUMORFU_1 using PROSITE identified several possible
phosphorylation and myristylization sites, and one amidation site
within the protein sequence, but as yet there is no indication that any
of these post-translational modifications occur. One of these possible
modifications, or another which has yet to be identified, may be
responsible for the more basic pI seen experimentally for eIF4H (8.5)
than was predicted (7.79) (Fig. 7A). Alternatively, eIF4H
may have been proteolytically cleaved at the C terminus during
purification resulting in an increase in pI (see "Results").
Analysis of the amino acid sequence of HUMORFU_1 using the PHD
structural prediction program (at EMBL-Heidelberg) predicted its
structure to be an -
protein.
Searches for eIF4H homologs in the various data bases identified several proteins with a significant degree of homology. The sequence for HUMORFU_1 was found to have a 39% identity and 62% similarity to that for human eIF4B (611 amino acids), a 25% identity and 53% similarity to the sequence for Tif3/Stm1 (translation initiation factor 3/suppressor of translation mutations) from Saccharomyces cerevisiae (436 amino acids), and a 39% identity and 62% similarity to the sequence from Schizosaccharomyces pombe for Sce3 (suppressor of cdc eleven) (388 amino acids) (all homologies calculated using the program GAP from Genetics Computer Group, Inc.). The Tif3/Stm1 protein has been described as the eIF4B homolog in S. cerevisiae (29, 30), which is 28% identical and 49% similar to human eIF4B, and the yeast Sce3 protein encodes a putative RNA-binding protein that is homologous to human eIF4B (31) (35% identical and 53% similar). It is not surprising that eIF4H is homologous to the yeast Tif3/Stm1 protein, considering eIF4H's similarity to human eIF4B. Since the Sce3 sequence is more closely related to eIF4H than eIF4B, and there is less disparity in the molecular weight, it may be possible that the yeast Sce3 protein is the eIF4H rather than the eIF4B homolog in S. pombe. Yet more detailed functional studies need to be done with this yeast protein to determine its function in translation.
By using the sequence alignment program ALIGN, a particular portion of the sequence for eIF4H (HUMORFU_1) between residues 36 and 117 was found to share a 45% identity to the eIF4B sequence between residues 90 and 172 (Fig. 8). This same sequence from eIF4H shares a 43% identity to residues 88-169 of Sce3 (which is 45% identical to residues 90-172 of eIF4B) and a 28% identity to residues 95-182 of Tif3/Stm1 (32% identical to residues 90-172 of eIF4B). This portion of the eIF4B includes the ribonucleoprotein consensus sequence (RNP-CS)/RNA recognition motif (RRM) which is located between residues 97 and 175 (32). RRM domains are found in other RNA-binding proteins, such as the poly(A)-binding protein, U1A snRNP, and the 70 kDa snRNP, and are characterized as containing the two highly conserved RNP-1 and RNP-2 domains (33). The RNP-2 domain is typically located amino-terminal to the RNP-1 domain and is characterized as a hydrophobic segment of six residues. The RNP-1 octapeptide motif has a consensus sequence of (RK)-G-(EDRKHPCG)-(AGSCI)-(FY)-(LIVA)-X-(FYM). The amino acid sequence for HUMORFU_1 contains an RNP-1 RNA-binding site between residues 82 and 89, and by analysis of the sequence alignment, a possible RNP-2 motif may exist between residues 44 and 49 that has a high degree of identity to the RNP-2 domains of eIF4B, Sce3, and Tif3/Stm1 (Fig. 8). The presence of these RNA-binding motifs in eIF4H is consistent with the preliminary results seen with eIF4H in its binding and cross-linking to globin mRNA.
|
The RRM of eIF4B is thought to facilitate mRNA recognition and binding along with the basic region between residues 367 and 423 (32). This RRM region is not essential for RNA binding of eIF4B, but is required for the maximal stimulation of the eIF4A helicase activity (32). Since this RRM region in eIF4B is 45% identical to a segment of nearly identical length in eIF4H, it may suggest that eIF4H can also stimulate the helicase activity of eIF4A as it did the ATPase activity. This hypothesis has not been specifically addressed here in this article, but will be investigated in future studies. In addition, this similar RRM region within Tif3/Stm1 was also found to be important for its function since site-directed mutagenesis within the RNP domains eliminated the protein's suppressor activity (30). This finding adds to the possible importance of this RRM region within eIF4H for its translational activity.
It is possible that eIF4H may facilitate the ability of some of the other initiation factors to overcome negative regulation, such as inhibition of eIF4E by 4E-BP1 (34, 35); or even enhance their positive regulation, such as the enhancement of eIF4A's activities by eIF4B (1, 23). Closer examination of the titration curves in Figs. 3 and 4 show that eIF4H can greatly stimulate the activities at limiting amounts of eIF4B, and suggests that eIF4H serves as a positive regulator of protein synthesis at the level of initiation. eIF4H may also have an effect on the translation of different messages, where it may facilitate the translation of inefficient messages, or even affect internal initiation. The fact that eIF4H appears to stimulate the ATP-dependent process of mRNA binding to ribosomes offers the possibility that it may influence the competition between different mRNAs for translation.
It is estimated that ~1 mg of eIF4H can be purified from 6 liters of rabbit reticulocyte lysate. This is ~5- to 10-fold less than the milligram amounts of eIF4B or eIF4F and ~100-fold less than the mg amounts of eIF3 which can be obtained from the same volume of starting material (these are based on purification and may not reflect actual relative levels intercellularly). Low levels of eIF4H are also seen relative to ribosomal proteins during analysis of polysomal proteins by two-dimensional gel electrophoresis (Fig. 7, B and C). These limited amounts of eIF4H relative to other initiation factors also support the hypothesis that eIF4H plays a role as a stimulatory or regulatory factor in translation. It is known that the relative concentration of translation factors in different tissues in mammalian systems varies significantly, but at this point there is little experimental data evaluating the protein levels of eIF4H relative to other mRNA binding factors (eIF4A, eIF4B, or eIF4F) in discrete tissues, or its effect on differential translation of mRNAs in these tissue extracts.
This report has provided evidence for a new eukaryotic initiation factor, eIF4H, which stimulates protein translation. This new factor has been the first to be biochemically identified within the past 14 years since the identification of eIF4F. Current research on eIF4H involves studies of this new factor's activities and interactions with other components involved in the initiation of protein synthesis in eukaryotes. These studies will help determine relative affinities of eIF4H for other protein factors as well as mRNA, and may help identify where in the process of mRNA binding and utilization eIF4H functions. Future studies will also analyze possible post-translational modifications of eIF4H and any effect these may have on activity. In addition, eIF4H's concentration within various tissues will be measured and it will be determined whether this influences competition for mRNA translation.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank Cheryl L. Owens (Molecular Biology Core Laboratory, Case Western Reserve University) for assistance in amino acid analysis and amino acid sequencing , and Dr. Nahum Sonenberg and members of his laboratory (Department of Biochemistry and McGill Cancer Center, McGill University, Montreal, Canada) for performing the UV cross-linking studies. We also especially thank Diane Barth-Baus for performing the two-dimensional PAGE experiments.
![]() |
FOOTNOTES |
---|
* This work was supported in part by National Institutes of Health Grants DK 07319 (to N. J. R.-C. and T. E. D.), DK 43414 (to J. O. H.), and GM 26796 (to W. C. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Current address: National Institutes of Health, Bethesda, MD
20892.
¶ To whom correspondence should be addressed: Dept. of Biochemistry, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106-4935. Tel.: 216-368-3578; Fax: 216-368-3419; E-mail: wcm2{at}po.cwru.edu.
1 The abbreviations used are: Met-tRNAi, initiator methionyl-tRNA; m7G, 7-methylguanosine; eIF, eukaryotic initiation factor; eEF, eukaryotic elongation factor; 3°, ternary complex; HPLC. high pressure liquid chromatography; IEF, isoelectric focusing; PAGE, polyacrylamide gel electrophoresis; NEPHGE, nonequilibrium pH gradient electrophoresis; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate; DTT, dithiothreitol; SB, standard buffer; RRM, RNA recognition motif.
2
The protein translation factors formerly known
as EF-1, eIF-4C, and EF-1
have been named eEF1A, eIF1A, and
eEF1B
, respectively, in this article as suggested by the
Nomenclature Committee of the International Union of Biochemistry and
Molecular Biology (IUBMB) (see Merrick and Hershey (1)). This new
nomenclature has not yet been approved by the IUBMB.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|